Testing effectiveness (Phase 2)Ended earlyNCT03065023
What this trial is testing
Study of Intralesional Administration of MK-4621 (RGT100) in Adult Participants With Advanced or Recurrent Tumors (MK-4621-001/RGT100-001)
Who this might be right for
Advanced Solid Tumors
Merck Sharp & Dohme LLC 15